NYSE:BRO
Related posts
Nervous markets await NvidiaThis summary was created by AI, based on 1 opinions in the last 12 months.
Brown & Brown (BRO-N) has garnered attention as a top pick among analysts, with significant growth of 25.58% noted recently. The company operates in the property and casualty insurance sector, a field that has faced numerous challenges such as natural disasters and the impacts of the pandemic. These factors contribute to volatility in the sector, particularly affecting valuations. An analyst decided to sell the stock as the valuation reached what was perceived as excessive, indicating a cautious stance on future performance. While the company's fundamentals remain strong, experts seem to suggest vigilance regarding the stock's price in relation to its inherent value amidst an unpredictable insurance landscape.
Brown & Brown is a American stock, trading under the symbol BRO-N on the New York Stock Exchange (BRO). It is usually referred to as NYSE:BRO or BRO-N
In the last year, 2 stock analysts published opinions about BRO-N. 2 analysts recommended to BUY the stock. 0 analysts recommended to SELL the stock. The latest stock analyst recommendation is . Read the latest stock experts' ratings for Brown & Brown.
Brown & Brown was recommended as a Top Pick by on . Read the latest stock experts ratings for Brown & Brown.
Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.
2 stock analysts on Stockchase covered Brown & Brown In the last year. It is a trending stock that is worth watching.
On 2025-08-15, Brown & Brown (BRO-N) stock closed at a price of $95.34.
BRO is a $31.6B insurance name which is down 9% year-to-date, but over the past five years it has a ~17% total return CAGR. It pays a small yield of 0.6%, it has grown its sales and earnings at a 14.8% and 17.9% annualized return, respectively. Forward growth estimates are strong, and its fundamentals are solid. The entire insurance industry is likely heading into a 'hard market', which can negatively impact profits, but for a long-term holding, we continue to like this name.
The acquisition of Accession Risk for $9.8B is a large-scale acquisition, potential expanding its market reach in specialty and wholesale channels. There are some risks on the integration of this acquisition, but it has a successful track record of integrations. We think for a long-term, more defensive holding, we would be comfortable buying here.
Unlock Premium - Try 5i Free